Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation
- PMID: 36602260
- DOI: 10.1111/all.15637
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation
References
REFERENCES
-
- Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993-1002.
-
- Harkness LM, Ashton AW, Burgess JK. Asthma is not only an airway disease, but also a vascular disease. Pharmacol Ther. 2015;148:17-33.
-
- Zhang Y, Zhang Y, Kameishi S, et al. The Amot/integrin protein complex transmits mechanical forces required for vascular expansion. Cell Rep. 2021;36:109616.
-
- Aulakh GK, Balachandran Y, Liu L, Singh B. Angiostatin inhibits activation and migration of neutrophils. Cell Tissue Res. 2014;355(2):375-396.
-
- Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. Angiomotin an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol. 2001;152:1247-1254.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical